Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 16th World Cardiology Congress Dubai, UAE.

Day 1 :

Keynote Forum

Guy Hugues Fontaine

Pitié-Salpêtrière Hospital, France

Keynote: First histologic demonstration of Atrial Dysplasia in two ARVD patients

Time : 10:00 AM

OMICS International World Cardiology 2016 International Conference Keynote Speaker Guy Hugues Fontaine photo
Biography:

Guy Fontaine has made 15 original contributions at the inception of cardiac pacemakers in the mid-60s. He has identified ARVD by serendipity in the late 70s, published 900 scientific papers including 201 book chapters. He is in the 3 books: 216 Profiles in Cardiology since the 14th century (Hurst 2003), “500 greatest Geniuses of the 21th century” (ABI) 2005 USA, the “100 Life time of Achievement” (IBC) 2005 Cambridge UK. Reviewer of 17 journals both in clinical and basic Science. He has given 11 master lectures in China (2014). He is also working on brain and heart protection in cardiac arrest and stroke by therapeutic hypothermia.

Abstract:

Since the reproduction of the disease-in-the-dish by the group of San Diego (Kim Nature 2013), the original term of ARVD is now back in Force (Fontaine Editorial AJC 2014). ARVD has been discovered by its disorder in ventricular abnormal activation leading to premature reactivation of myocardium called an extrasystole producing a basic bump in the chest. In a most severe form several consecutive bumps are observed poorly tolerated by women when they are frequent. In the worst situation this abnormal fast cardiac activity may result in sudden unexpected death. The disease is the result of a genetic anomaly mostly affecting the RV in which the myocardium is occupied bat fat and fibrosis. In addition, presence of lymphocytes is the marker of poor prognosis. In anecdotal cases it was observed that patients later confirmed as typical ARVD had atrial arrhythmias as the first presentation of the disease suggesting that the disease can start by the atrium before the ventricle and that atrium was also involved. This concept has been recently confirmed and published. However, I am the first to study the histology of the atrium in two patients with known ARVD who died suddenly in whom I performed myself the extraction of the heart immediately after death and in whom samples were taken from both ventricles and atria giving perfect gross pathology before immersion in formalin.

Special histologic staining was performed to clearly identify fibrosis. In the first patient only severe interstitial fibrosis was observed all over right and left ventricle. In the second patient a less severe interstitial fibrosis was observed but was associated to replacement fibrosis with some lymphocytes suggesting superimposed myocarditis.

The systematic study of the right ventricle of 82 individuals who died of non-cardiac cause in a general hospital showed that 3.7% had the histologic pattern of RVD and not ARVD since those individuals had non arrhythmias. Therefore, these cases represent the quiescent form of ARVD. It is therefore possible to consider that the same situation exists in the general population as far as atrial dysplasia is concerned. This situation may lead to atrial fibrillation spontaneously because of the anatomic creation of an anatomic substrate or it could a more stable form which become arrhythmogenic in case of superimposed myocarditis (Bonny CRP 2001).

Break: Networking & Refreshments Break 11:00-11:20 @ Foyer

Keynote Forum

Rainer Moosdorf

University Hospital of Giessen and Marburg, Germany

Keynote: Minimally invasive procedures in heart surgery from VT ablation to special accesses in TAVIs

Time : 11:20 AM

OMICS International World Cardiology 2016 International Conference Keynote Speaker Rainer Moosdorf photo
Biography:

Rainer Moosdorf is working in the field of Cardiovascular Surgery since more than 35 years. He started his career as a Resident at University Hospital in Giessen in 1978. In 1990, he became a full Professor for Cardiovascular Surgery at University in Bonn and Vice Chairman of the respective department. In 1989 and 1990, he was a Researcher and Clinical Fellow at Carolinas Heart Institute in Charlotte/NC. Since 1994, he has been working at University Hospital in Marburg as a full Professor for Cardiovascular Surgery and Director of the Department. Between 2001 and 2011, he was Vice Medical Director and since 2006, Medical Director at University Hospital in Marburg. His main specialties within cardiovascular surgery are “Laser and arrhythmia surgery, endovascular procedures including TAVI´s and endovascular reconstructions of the aortic arch, reconstructive surgery of the coronaries and some types of the French correction”. As Chairman of the board of Medical Network Hessen, he is an official representative of the State of Hessen in the field of Clinical Medicine and Medical Education.

Abstract:

Minimally invasive interventions have gained much interest in many surgical disciplines and also in cardiovascular surgery. Many of them are not truly minimal but less invasive as compared to interventional cardiology with its small puncture sites; even small thoracotomies are bigger and accordingly not minimally invasive. However, even less invasive procedures reduce the surgical burden for the sick heart and the increasingly sicker and elder patients. This shall be demonstrated by two different examples from opposite ends of the line. Ventricular Tachycardia (VT) is life threatening arrhythmias arising from scar areas, mainly following myocardial infarctions. The established therapy today is the implantation of ICDs to prevent sudden cardiac death. However, this is a palliative approach and many, especially younger patients are limited in their daily and professional life by syncope and potential shocks. A significant number of these patients have to undergo open heart surgery because of diffuse coronary artery disease or the sequel of a myocardial infarction like ventricular aneurysms. A simple mapping guided laser assisted ablation of the VT foci during such surgery may terminate the VTs, making an ICD implantation unnecessary, or at least reduce the arrhythmic burden in such a way that frequent VTs or even VT storms do not occur and ICD shocks become a rare event. With the introduction of the laser technique, these interventions are no longer consist of large resection but of small ablation spots, which may even be limited to the epicardial surface of the heart in suitable cases. Less invasive techniques have in these cases widened the spectrum of curative options in contrast to the palliative ICD. On the other end of the line, catheter based implantation techniques for the aortic (TAVI) and in near future also for the mitral valve has opened the doors for a large number of elderly and multi-morbid patients, who are formerly excluded from open heart surgery because of an incalculable risk. Many of them again show up with significant cardiovascular comorbidities which necessitate alternative procedures and approaches. Up to ¼ of elderly patients with a heart disease also suffer from symptomatic carotid artery disease. They may offer a combined approach of carotid endarterectomy even under local anesthesia followed by a transcarotid TAVI via the same access and special techniques may avoid a negative impairment of carotid perfusion during valve implantation. Even if open heart procedures are indicated in these elderly patients, additional to an aortic valve replacement, a transaortic direct TAVI may reduce cross clamp and operating time significantly and accordingly reduce the risk and provide a realistic therapeutic option. Some of these special techniques have been further developed at our department during recent years and shall be demonstrated with their results.